Novo Nordisk A/S Class B (0QIU) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 May 2026 11:25 AM
GNW
Novo Nordisk A/S: Wegovy® delivered substanti...
12 May 2026 07:00 AM
GNW
Novo Nordisk A/S: Higher dose Wegovy® demonst...
06 May 2026 06:31 AM
GNW
Novo Nordisk's adjusted operating profit reac...
28 Apr 2026 01:00 PM
GNW
Novo Nordisk to present new data on Wegovy®, ...
23 Apr 2026 10:09 AM
GNW
Novo Nordisk’s oral semaglutide demonstrates ...
20 Apr 2026 10:19 AM
GNW
Novo Nordisk: Etavopivat is the first in a ne...
14 Apr 2026 07:00 AM
GNW
Novo Nordisk and OpenAI partner to transform ...
09 Apr 2026 01:28 PM
GNW
Novo Nordisk A/S: Wegovy® injection becomes f...
26 Mar 2026 11:36 PM
GNW
Novo Nordisk A/S: Awiqli® approved in the US,...
26 Mar 2026 03:15 PM
GNW
Resolutions from the Annual General Meeting o...
25 Mar 2026 06:00 AM
GNW
Novo Nordisk A/S: Triple agonist UBT251 showe...
19 Mar 2026 03:40 PM
GNW
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2...
02 Mar 2026 03:55 PM
GNW
Election of employee representatives to the B...
02 Mar 2026 09:00 AM
GNW
Novo Nordisk announces more than 400 million ...
25 Feb 2026 01:00 PM
GNW
Novo Nordisk and Vivtex partner to develop ne...
24 Feb 2026 08:39 AM
GNW
Novo Nordisk: Triple agonist UBT251 delivers ...
23 Feb 2026 09:33 AM
GNW
Novo Nordisk A/S: CagriSema demonstrated 23% ...
20 Feb 2026 12:02 PM
GNW
Novo Nordisk A/S: Notice for the Annual Gener...
17 Feb 2026 01:58 PM
GNW
Novo Nordisk A/S: The European Commission app...
05 Feb 2026 03:45 PM
GNW
Novo Nordisk issues statement on illegal mass...
04 Feb 2026 02:53 PM
GNW
Novo Nordisk files annual report with the SEC
04 Feb 2026 07:00 AM
GNW
Novo Nordisk initiates 2026 share repurchase ...
04 Feb 2026 06:30 AM
GNW
Novo Nordisk has published its annual report ...
03 Feb 2026 04:38 PM
GNW
Novo Nordisk's sales increased by 6% in Danis...
03 Feb 2026 04:37 PM
GNW
Novo Nordisk releases 2026 sales and operatin...
02 Feb 2026 03:42 PM
GNW
Novo Nordisk A/S: CagriSema demonstrated supe...
31 Jan 2026 07:00 AM
GNW
New employee representative on the Board of D...
20 Jan 2026 01:30 PM
GNW
Aspect Biosystems and Novo Nordisk enter new ...
31 Dec 2025 01:24 PM
GNW
Novo Nordisk A/S: China’s Supreme People’s Co...
22 Dec 2025 10:50 PM
GNW
Novo Nordisk A/S: Wegovy® pill approved in th...
12 Dec 2025 01:57 PM
GNW
Novo Nordisk A/S: More efficacious dose of We...
09 Dec 2025 01:51 PM
GNW
Novo Nordisk has completed its acquisition of...
25 Nov 2025 11:24 AM
GNW
Novo Nordisk phase 2 trial with amycretin rep...
24 Nov 2025 11:20 AM
GNW
Novo Nordisk A/S: Evoke phase 3 trials did no...
14 Nov 2025 02:21 PM
GNW
Resolutions from the Extraordinary General Me...
13 Nov 2025 10:38 PM
GNW
Novo Nordisk A/S: Candidate for the Board of ...
06 Nov 2025 06:00 PM
GNW
Novo Nordisk announces agreement with the U.S...
05 Nov 2025 09:30 PM
GNW
Novo Nordisk Wegovy® users achieved waist and...
05 Nov 2025 06:30 AM
GNW
Novo Nordisk's sales increased by 12% in Dani...
30 Oct 2025 09:49 AM
GNW
Novo Nordisk submits proposal to acquire Mets...
21 Oct 2025 01:02 PM
GNW
Notice convening an Extraordinary General Mee...
21 Oct 2025 12:56 PM
GNW
Novo Nordisk announces an Extraordinary Gener...
15 Oct 2025 01:30 PM
GNW
Novo Nordisk and Omeros announce asset purcha...
09 Oct 2025 11:00 AM
GNW
Novo Nordisk to acquire Akero Therapeutics an...
18 Sep 2025 09:45 AM
GNW
Novo Nordisk A/S: Ozempic® reduces the risk o...
17 Sep 2025 10:05 PM
GNW
Novo Nordisk’s oral semaglutide 25 mg (Wegovy...
16 Sep 2025 11:00 AM
GNW
Novo Nordisk presents phase 3 data for next-g...
15 Sep 2025 11:03 PM
GNW
People taking Novo Nordisk’s Wegovy® experien...
15 Sep 2025 01:00 PM
GNW
EU approval makes Novo Nordisk’s oral semaglu...
10 Sep 2025 06:00 AM
GNW
Novo Nordisk to streamline operations and rei...
UK 100

Latest directors dealings